Log in to save to my catalogue

Post-transplantation cyclophosphamide is associated with increased bacterial infections

Post-transplantation cyclophosphamide is associated with increased bacterial infections

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11164622

Post-transplantation cyclophosphamide is associated with increased bacterial infections

About this item

Full title

Post-transplantation cyclophosphamide is associated with increased bacterial infections

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2024-01, Vol.59 (1), p.76-84

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Post-transplant cyclophosphamide (PTCy) is increasingly used to reduce graft-versus-host disease after hematopoietic cell transplantation (HCT); however, it might be associated with more infections. All patients who were ≥2 years old, receiving haploidentical or matched sibling donor (Sib) HCT for acute leukemias or myelodysplastic syndrome, and ei...

Alternative Titles

Full title

Post-transplantation cyclophosphamide is associated with increased bacterial infections

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11164622

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11164622

Other Identifiers

ISSN

0268-3369,1476-5365

E-ISSN

1476-5365

DOI

10.1038/s41409-023-02131-z

How to access this item